Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy ...

A Durham man with stage four lung cancer credits a Duke clinical trial for giving him his life back. The trial is funded by ...

Former Minnesota Viking John Randle attended a fundraiser in Faribault on Saturday supporting a navy veteran.34-year-old Dale ...

David Spigel, MD, discusses the significant benefits of durvalumab as consolidation therapy following standard ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

In Sharmila Tagore’s cancer case, early detection was the game changer. Her story serves as both a cautionary tale and a ...

Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

The poster presented data from AUTX-703, a potent, selective and orally bioavailable heterobifunctional degrader of KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung ...

2 "With this approval, we can now offer immunotherapy treatment to people living with limited-stage small cell lung cancer, which is almost always fatal, even in patients with limited disease ...